Company intelligence / Profile preview

Jilin Jinkangan Pharmaceutical

Yanbian Korean Autonomous Prefecture, Jilin, Chinachictr.org.cn ↗

Ownership: Private
Development stage: Other

Overview

Jilin Jinkang An Pharmaceutical is an active Chinese pharmaceutical and medical device company founded in 2018. It focuses on the sales of medicines and the production of Class-II and Class-III medical devices, particularly for ICU, anesthesia, and respiratory care. The company has established strategic partnerships with international firms to co-develop new products[7][4]. No specific clinical trial results or drug approvals are publicly available.

Modalities: Small moleculeMedical device
Industry: Biotech

Partnerships

Daeyomedi Corporation (South Korea)Seoil Pacific Corporation (South Korea)BrainU Corporation (South Korea)Mespere Lifesciences (Canada)

Beyond the preview

Go deeper on Jilin Jinkangan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jilin Jinkangan Pharmaceutical.

Explore the full profile